Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
The Common Services Agency (more commonly known as NHS National Services Scotland) (‘NSS’)
Gyle Square (NSS Head Office), 1 South Gyle Crescent
Edinburgh
EH12 9EB
UK
Contact person: Linda Downie
Telephone: +44 1698794571
E-mail: l.downie@nhs.net
NUTS: UKM
Internet address(es)
Main address: http://www.nhsscotlandprocurement.scot.nhs.uk/
Address of the buyer profile: https://www.publiccontractsscotland.gov.uk/search/Search_AuthProfile.aspx?ID=AA11883
I.2) Joint procurement
The contract is awarded by a central purchasing body
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Compounded Aseptic Medicines
Reference number: NP38619
II.1.2) Main CPV code
33600000
II.1.3) Type of contract
Supplies
II.1.4) Short description
This framework agreement is for the supply of unlicensed, aseptically compounded, ready to use medicines in syringe and infusion bags to NHS Scotland.
The goods have been separated into four (4) categories, each of which is identified as a ‘Lot’. Full details of each lot is contained in section II.2 of this notice.
II.1.6) Information about lots
This contract is divided into lots:
Yes
II.1.7) Total value of the procurement
Value excluding VAT:
63 213 953.00
GBP
II.2) Description
Lot No: 1
II.2.1) Title
Compounded Aseptic Medicines
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any integrated joint boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses:
Atezolizumab
Cetuximab
Doxorubicin
Epirubicin
Infliximab (Inflectra®), (Remicade®), (Remsima®)
Nivolumab
Pembrolizumab
Pertuzumab
The authority has awarded all presentations within this lot to a single supplier.
II.2.5) Award criteria
Quality criterion: Stability
/ Weighting: 10
Quality criterion: Capacity
/ Weighting: 10
Quality criterion: Contingency
/ Weighting: 10
Quality criterion: Communication
/ Weighting: 10
Price
/ Weighting:
60
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 2
II.2.1) Title
Compounded Aseptic Medicines
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses:
Cyclophosphamide
Fluorouracil
Irinotecan
Methotrexate
Rituximab (Mabthera®), (Rixathon®), (Truxima®)
The authority has awarded all presentations within this lot to a single supplier.
II.2.5) Award criteria
Quality criterion: Stability
/ Weighting: 10
Quality criterion: Capacity
/ Weighting: 10
Quality criterion: Contingency
/ Weighting: 10
Quality criterion: Communication
/ Weighting: 10
Price
/ Weighting:
60
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 3
II.2.1) Title
Compounded Aseptic Medicines
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UKM
Main site or place of performance:
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any integrated joint boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses:
Bortezomib
Carboplatin
Cisplatin
Docetaxel
Gemcitabine
Oxaliplatin
Trastuzumab (Herceptin®), (Herzuma®)
Vincristine
The authority has awarded all presentations within this lot to a single supplier.
II.2.5) Award criteria
Quality criterion: Stability
/ Weighting: 10
Quality criterion: Capacity
/ Weighting: 10
Quality criterion: Contingency
/ Weighting: 10
Quality criterion: Communication
/ Weighting: 10
Price
/ Weighting:
60
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Lot No: 4
II.2.1) Title
All Other Presentations
II.2.2) Additional CPV code(s)
33600000
II.2.3) Place of performance
NUTS code:
UK
Main site or place of performance:
All entities constituted pursuant to the National Health Services (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to New Public Bodies (Joint Working) Scotland Act 2014.
II.2.4) Description of the procurement
Supply of the following aseptically compounded, ready to use medicines in syringes and infusions to NHS Scotland in a range of doses:
The molecules included in this lot are:
Bevacizumab
Cytarabine
Infliximab (Zessly®)
Insulin
Methotrexate
Natalizumab
Nivolumab
Paclitaxel
Pemetrexed
Tocilizumab
Trastuzumab (Kanjinti®), (Ontruzant®)
Trastuzumab Subcutaneous
Vedolizumab.
Each product line was treated as an individual lot and awarded as an unranked multi-supplier framework.
II.2.5) Award criteria
Quality criterion: Stability
/ Weighting: 10
Price
/ Weighting:
90
II.2.11) Information about options
Options:
No
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Open procedure
IV.1.3) Information about a framework agreement or a dynamic purchasing system
The procurement involves the establishment of a framework agreement
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
Yes
IV.2) Administrative information
IV.2.1) Previous publication concerning this procedure
Notice number in the OJ S:
2019/S 187-454140
Section V: Award of contract
Lot No: 1
Title: Compounded Aseptic Medicines
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
14/02/2020
V.2.2) Information about tenders
Number of tenders received: 2
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 2
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Baxter Healthcare Ltd
Wallingford Road, Compton
Newbury, Berkshire
RG20 7QW
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 14 934 164.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 2
Title: Compounded Aseptic Medicines
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
14/02/2020
V.2.2) Information about tenders
Number of tenders received: 3
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 0
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Qualasept Ltd t/a Bath ASU
Unit A15 Fiveways Light Industrial Estate, Westwells Road
Corsham
SN13 9RG
UK
NUTS: UKM
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 15 129 581.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 3
Title: Compounded Aseptic Medicines
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
14/02/2020
V.2.2) Information about tenders
Number of tenders received: 3
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 3
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Baxter Healthcare Ltd
Wallingford Road, Compton
Newbury, Berkshire
RG20 7QW
UK
NUTS: UK
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 7 500 671.00
GBP
V.2.5) Information about subcontracting
Section V: Award of contract
Lot No: 4
Title: All Other Presentations
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
14/02/2020
V.2.2) Information about tenders
Number of tenders received: 3
Number of tenders received from SMEs: 0
Number of tenders received from tenderers from EU Member States: 0
Number of tenders received from tenderers from non-EU Member States: 0
Number of tenders received by electronic means: 3
The contract has been awarded to a group of economic operators:
Yes
V.2.3) Name and address of the contractor
Baxter Healthcare Ltd
Wallingford Road, Compton
Newbury, Berkshire
RG20 7QW
UK
NUTS: UK
The contractor is an SME:
No
V.2.3) Name and address of the contractor
Qualasept Ltd t/a Bath ASU
Unit A15 Fiveways Light Industrial Estate, Westwells Road
Corsham
SN13 9RG
UK
NUTS: UKM
The contractor is an SME:
No
V.2.3) Name and address of the contractor
ITH Pharma Ltd
Unit 4 Premier Park, Premier Park Road
London
NW10 7NZ
UK
NUTS: UKM
The contractor is an SME:
No
V.2.4) Information on value of the contract/lot (excluding VAT)
Total value of the contract/lot:
: 25 649 538.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
The estimated value referred to in Sections II.I.5) and within each Lot covers the thirty six (36) month framework duration and the twelve (12) month extension period.
(SC Ref:616012)
VI.4) Procedures for review
VI.4.1) Review body
Edinburgh Sheriff Court
Sheriff Court House, 27 Chambers Street
Edinburgh
EH1 1LB
UK
E-mail: edinburgh@scotcourts.gov.uk
VI.4.3) Review procedure
Precise information on deadline(s) for review procedures:
The bringing of court proceedings against the authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
VI.5) Date of dispatch of this notice
13/03/2020